Freed B A, Hsia B, Smith J P, Kaminski M V
JPEN J Parenter Enteral Nutr. 1981 Jan-Feb;5(1):40-5. doi: 10.1177/014860718100500140.
A retrospective study was undertaken to determine with what frequency one of the 12 standard enteral formulations routinely used by the Metabolic Support Service could not be used without modification. Forty-three percent of the 83 patients studied required modification of one or more of the 5 individual components of the enteral product being utilized (ie, carbohydrate, protein, fat, electrolytes, and vitamins). Organ dysfunction was the reason for 31% of those changes in formula, other conditions included vitamin deficiencies (30%), electrolyte imbalances (27%), and essential fatty acid deficiencies (12%). The results of the study confirm the fact that no single formula can be effective in meeting every patient's fluid and electrolyte requirements while addressing the specific nutritional aspects of their disease. It would appear that a totally modular system for enteral nutrition similar to that used in parenteral nutritional support would allow maximum flexibility in the preparation of formulae that conform to patient's needs.
进行了一项回顾性研究,以确定代谢支持服务常规使用的12种标准肠内制剂中,有多少种在不进行调整的情况下无法使用。在83例研究患者中,43%的患者需要对所使用的肠内产品的5种单独成分中的一种或多种进行调整(即碳水化合物、蛋白质、脂肪、电解质和维生素)。器官功能障碍是31%的配方改变的原因,其他情况包括维生素缺乏(30%)、电解质失衡(27%)和必需脂肪酸缺乏(12%)。研究结果证实了这样一个事实,即没有一种单一的配方能够有效地满足每个患者的液体和电解质需求,同时解决其疾病的特定营养方面问题。看来,类似于肠外营养支持中使用的完全模块化肠内营养系统,将在制备符合患者需求的配方时提供最大的灵活性。